Increased BACE1 activity could be attributed to insulin resistance phenotypic effects of depleting PPAR-δ since insulin resistance increases BACE1 activity and metformin treatment of other AD models reduces BACE1 and Aβ generation [43]. This evidence concerns the gene BACE1 and Alzheimer disease.